Hadar Goldvaser

ORCID

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 7

Top Venues

Cancer medicine

Breast cancer research and treatment

JNCI cancer spectrum

Journal of cancer research and clinical oncology

Rabin Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rabin Medical Center Apr 1o 2010

Israel

Medical Oncologist :: Davidoff Cancer Center

Publications

Michal Sternschuss, Rinat Yerushalmi, Ramy R Saleh, Eitan Amir, Hadar Goldvaser
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 147 (11) (2021)
Daniel Reinhorn, Rinat Yerushalmi, Assaf Moore, Alexandra Desnoyers, Ramy R Saleh, Eitan Amir, Hadar Goldvaser
Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer. Breast cancer research and treatment 182 (2) (2020)
Daniel A Goldstein, Chen Mayer, Tzippy Shochat, Daniel Reinhorn, Assaf Moore, Michal Sarfaty, Rinat Yerushalmi, Hadar Goldvaser
The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real-world early-stage breast cancer. Cancer medicine 9 (13) (2020)
Yulia Kundel, Michal Sternschuss, Assaf Moore, Gali Perl, Baruch Brenner, Hadar Goldvaser
Efficacy of immune-checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta-analysis. Cancer medicine 9 (20) (2020)
Yasmin Korzets, Anthony Fyles, Daniel Shepshelovich, Eitan Amir, Hadar Goldvaser
Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis. Breast cancer research and treatment 175 (3) (2019)
Hadar Goldvaser, Yasmin Korzets, Daniel Shepshelovich, Rinat Yerushalmi, Michal Sarfaty, Domen Ribnikar, Paaladinesh Thavendiranathan, Eitan Amir
Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis. JNCI cancer spectrum 3 (2) (2019)
Hadar Goldvaser, Shulamith Rizel, Daniel Hendler, Victoria Neiman, Daniel Shepshelovich, Tzippy Shochat, Aaron Sulkes, Baruch Brenner, Rinat Yerushalmi
The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics. International journal of endocrinology 2016 (2016)

Hadar Goldvaser.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hadar Goldvaser